Print Friendly, PDF & Email

NCT/Study#

NCT02523014 /

A071401

Phase II Trial Of SMO/AKT/NF2 Inhibitors In Progressive Meningiomas With SMO/AKT/NF2 Mutations

DISEASE GROUP:

Neuro-Oncology

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587